SGP
SpyGlass Pharma, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About SpyGlass Pharma, Inc. Common Stock
SGP is a leading provider of innovative biopharmaceutical solutions, focused on developing and commercializing therapies for a range of critical health conditions. With a robust pipeline and a commitment to research and development, SGP leverages advanced technologies to address unmet medical needs and enhance patient outcomes. The company's strategic partnerships and collaborations further bolster its market position and drive growth initiatives, making it a compelling investment opportunity for institutional investors seeking exposure to the evolving biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026